New 140,000-square-foot facility will advance fundamental chemistry and materials science for higher-performing, cost-effective catalysts and batteries, and other energy efficiency technologies.

As the COVID-19 pandemic continues, PNNL is offering support to its neighbors in the Mid-Columbia region and across Washington State.

Genetic and integrated multi-omic details of glioblastoma could one day inform new therapies.

Connected moments math shortcut shaves time and cost of quantum calculations while maintaining accuracy.

Special issue highlights PNNL contributions to NWChem and CP2K, two prominent software packages for computational chemistry.

PNNL researchers are examining the volatile radioisotope iodine as it evolves in the atmosphere and as it lands on a filtering surface.

PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.

PNNL led a multi-institutional effort to design a highly active and more durable catalyst made from cobalt, which sets the foundation for fuel cells to power transportation, stationary and backup power, and more.

Project manager Larry Morgan has spent half a century at Pacific Northwest National Laboratory—marking one of the longest tenures in the laboratory’s history.

A new report outlines future research paths that are needed for airlines to reduce carbon emissions and notes that the only way to achieve emission reduction goals is with Sustainable Aviation Fuels.

Researchers at Pacific Northwest National Laboratory (PNNL) are closer to understanding how iron may pave the way for sequestration of technetium-99 contaminants in the subsurface.

Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.

PNNL researchers are looking for protein signatures that could provide information about how the body's immune system responds to COVID-19.

PNNL scientists have developed a catalyst that converts ethanol into C5+ ketones that can serve as the building blocks for everything from solvents to jet fuel.

A zoonotic coronavirus known as SADS-CoV that has killed many pigs has the ability to infect human cells, surprising scientists.

PNNL researchers are contributing expertise and hydrothermal liquefaction technology to a project that intercepts harmful algal blooms from water, treats the water, and concentrates algae for transformation to biocrude.

A PNNL engineering team has designed personal protective equipment in support of COVID-19 aid.

An award-winning ion separation technology developed at PNNL has been licensed for biomedical applications. Continued research aims to make the devices suitable for molecular analysis in the field.  

PNNL has three small-scale spectroscopy devices that are speeding up the testing and analysis of candidate novel materials used in energy storage research and environmental remediation.

Using a large repository of blood samples from military personnel, PNNL and Uniformed Services University scientists have discovered a group of 13 proteins that could provide early detection of head and neck cancers.